From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “Bmal1” 5

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Impact of rucaparib on circadian rhythms and adverse events in ovarian cancer: Insights from the MAMOC trial.
2025 Journal of Clinical Oncology conference-abstract Medicine PARP inhibition in cancer therapy Open access

Deeksha Malhan, Janina Hesse, Nina Nelson, Jessica Nguyen, Ouda Aboumanify, Josefin Garmshausen, +12 more

0

citations
Circadian rhythm disruption by PARP inhibitors correlates with treatment toxicity in patients with ovarian cancer and is a predictor of side effects
2025 EBioMedicine article Medicine PARP inhibition in cancer therapy Open access

Deeksha Malhan, Janina Hesse, Nina Nelson, Jessica Nguyen, Ouda Aboumanify, Josefin Garmshausen, +12 more

9

citations
Alterations in Rev-ERBα/BMAL1 ratio and glycated hemoglobin in rotating shift workers: the EuRhythDia study
2021 Acta Diabetologica article Neuroscience Circadian rhythm and melatonin Open access

Stefano Rizza, Alessio Luzi, Maria Mavilio, Marta Ballanti, Arianna Massimi, Ottavia Porzio, +9 more

31

citations
Impact of light therapy on rotating night shift workers: the EuRhythDia study
2022 Acta Diabetologica article Neuroscience Circadian rhythm and melatonin Open access

Stefano Rizza, Alessio Luzi, Maria Mavilio, Marta Ballanti, Arianna Massimi, Ottavia Porzio, +9 more

15

citations
Finding the culprit for the failure of the immune clock as time goes by
2022 Cardiovascular Research article Neuroscience Circadian rhythm and melatonin Open access

Emiel P. C. van der Vorst, Sandrine Lecour

0

citations

5 results